临床研究
Copyright ©The Author(s) 2023.
世界华人消化杂志. 2023-01-28; 31(2): 56-65
在线出版 2023-01-28. doi: 10.11569/wcjd.v31.i2.56
表1 人体测量指标及实验室检测指标的组间比较(mean±SD)
合计(n = 509)男性
女性
MAFLD(n = 319)非MAFLD(n = 20)PMAFLD(n = 154)非MAFLD(n = 16)P
年龄(岁)44.94±12.5841.01±11.2842.50±11.560.58252.34±11.2955.00±13.650.462
身高(cm)167.64±9.21172.26±6.92174.18±6.060.187158.10±5.08159.19±5.200.436
体重(kg)78.02±15.0484.40±13.56b64.27±6.57b<0.00169.14±10.38b53.34±5.51b<0.001
BMI(kg/m2)27.60±4.0128.35±3.62b20.7±2.10b<0.00127.62±3.65b21.01±1.55b<0.001
WC(cm)95.92±12.9099.02±12.43b80.10±5.89b<0.00193.4±11.30b77.15±6.75b<0.001
AC(cm)33.28±3.9034.39±2.91b28.72±1.89b<0.00132.27±2.87b26.77±1.96b<0.001
AMC(cm)26.55±2.5827.82±1.95b24.46±1.09b<0.00124.64±1.80b21.65±1.59b<0.001
Mw(kg)28.69±6.7432.43±5.24b27.90±3.10b<0.00122.01±2.91b19.33±2.20b0.001
Pw(kg)10.18±2.2311.43±1.71b9.90±1.04b<0.0017.95±0.96b7.06±0.74b0.001
Fw(kg)26.24±8.2926.50±7.94b13.55±3.14b<0.00128.34±7.70b16.76±3.55b<0.001
BFR(%)33.45±7.6230.95±5.71b20.98±3.67b<0.00140.47±6.14b31.24±4.71b<0.001
VFA(cm2)125.66±46.24120.01±41.81b62.14±14.96b<0.001150.05±44.98b84.70±22.82b<0.001
RMR(kcal/d)1501.71±357.171640.28±376.83a1464.95±106.06a0.0391253.34±107.67b1160.06±77.24b0.001
ALT(U/L)101.63±242.63113.36±267.70126.79±338.150.88277.72±177.3168.84±100.640.764
AST(U/L)64.39±157.9862.79±163.7580.04±184.610.72766.36±150.4862.63±74.140.869
TBIL(μmol/L)21.50±29.6922.01±28.9522.43±16.720.92920.92±33.5516.23±12.150.262
BUN(mmol/L)5.56±5.615.90±6.455.81±4.390.9564.91±3.764.66±1.980.686
CRE(μmol/L)83.71±133.8298.54±163.04101.48±132.340.93353.13±12.0754.59±12.540.675
UA(μmol/L)340.46±97.90373.84±93.54b298.73±84.79b0.003280.93±72.87267.93±83.830.561
TC(mmol/L)5.00±1.224.84±1.124.76±1.100.7805.26±1.186.03±2.320.226
TG(mmol/L)1.47±1.121.60±1.28a0.91±0.35a0.0321.31±0.72b0.90±0.33b<0.001
HDL-C(mmol/L)1.48±0.421.38±0.33a1.61±0.37a0.0301.61±0.412.13±1.100.143
LDL-C(mmol/L)2.91±0.932.86±0.932.54±0.800.1373.03±0.873.32±1.230.322
FBG(mmol/L)6.26±1.906.26±1.97b5.32±0.60b<0.0016.48±1.89b5.20±0.56b<0.001
PBG(mmol/L)10.18±4.7710.07±4.75b5.32±0.70b<0.00111.99±4.767.94±4.210.379
FINS(μIU/ml)20.32±13.3122.02±13.21b7.41±4.02b0.00819.40±13.22b6.19±3.38b<0.001
HbA1C(%)6.26±1.156.10±1.035.00±1.210.2956.72±1.315.28±1.020.282
HOMA-IR5.78±4.396.27±4.19b1.71±0.87b<0.0015.61±4.86b1.36±0.78b<0.001
TP(g/L)74.00±6.6174.47±6.06a66.48±14.11a0.04673.93±5.9772.66±7.720.532
ALB(g/L)45.89±5.8846.92±5.5244.33±5.510.09644.27±6.0342.39±7.060.318
PA(mg/L)159.44±70.81168.84±77.91174.85±50.650.731141.91±61.52155.02±53.600.478
TRF(g/L)2.65±1.962.48±1.102.26±0.580.3622.57±0.495.02±7.090.329
Hb(g/L)142.14±21.74149.17±20.95140.00±22.980.168130.42±15.79123.21±22.470.265
K(mmol/L)3.95±0.454.00±0.454.12±0.500.4183.83±0.403.85±0.510.908
Na(mmol/L)138.03±12.76139.08±2.14139.96±1.470.092135.33±22.56140.09±2.560.118
Ca(mmol/L)2.37±0.172.35±0.162.39±0.160.4212.40±0.132.44±0.400.786
P(mmol/L)1.17±0.381.18±0.471.19±0.500.9201.15±0.151.15±0.110.893
Mg(mmol/L)0.98±0.130.98±0.140.97±0.050.7780.97±0.130.98±0.160.873
Fe(μmol/L)24.04±12.5627.45±12.5124.50±12.760.52518.60±10.1925.33±16.030.253
25-(OH)D(μg/L)34.45±3.1234.43±3.9135.80±0.990.29934.39±2.2033.60±2.120.656
表2 BFR、VFA和RMR与各实验室检测指标之间的Spearman相关分析
rs-BFRPrs-VFAPrs-RMRP
ALT(U/L)-0.1010.008-0.0560.2250.191<0.001
AST(U/L)-0.0110.808-0.0260.572-0.0170.706
TBIL(μmol/L)-0.1260.006-0.0940.0390.0990.030
BUN(mmol/L)-0.0930.054-0.0710.1420.0490.312
CRE(μmol/L)-0.368<0.001-0.204<0.0010.486<0.001
UA(μmol/L)-0.0900.0570.0510.2850.418<0.001
TC(mmol/L)0.209<0.0010.1390.004-0.224<0.001
TG(mmol/L)0.1260.0080.230<0.0010.178<0.001
HDL-C(mmol/L)0.1570.0010.0420.390-0.283<0.001
LDL-C(mmol/L)0.194<0.0010.1450.003-0.1350.006
FBG(mmol/L)0.239<0.0010.257<0.001-0.0660.171
PBG(mmol/L)0.1440.2740.2150.099-0.0320.809
FINS(μIU/ml)0.1660.0190.037<0.0010.390<0.001
HbA1C(%)0.2380.0300.2470.023-0.1640.136
HOMA-IR0.1950.0060.405<0.0010.393<0.001
TP(g/L)0.0670.1410.0520.2610.0340.456
ALB(g/L)-0.0960.036-0.0390.3900.237<0.001
PA(mg/L)-0.0330.662-0.0180.8140.0730.332
Hb(g/L)-0.252<0.001-0.0640.2500.506<0.001
TFR(g/L)0.0360.664-0.0840.311-0.2340.004
K(mmol/L)-0.0830.249-0.0240.7340.1530.032
Na(mmol/L)0.0450.532-0.0120.873-0.0890.216
Ca(mmol/L)0.1470.0340.0930.180-0.1060.128
P(mmol/L)0.1220.0750.1190.083-0.7060.270
Mg(mmol/L)0.0010.990-0.0230.775-0.0020.978
Fe(μmol/L)-0.303<0.001-0.1870.0220.2740.001
25-(OH)D(μg/L)-0.2840.143-0.2970.1250.1970.315
表3 BFR、VFA和RMR预测MAFLD的AUC及界值
指标AUC(95%CI)P界值灵敏度特异度
合计BFR0.800(0.752-0.875)<0.00128.550.7710.694
VFA0.894(0.847-0.941)<0.00187.100.8500.833
RMR0.715(0.639-0.790)<0.0011497.500.5110.861
男性BFR0.934(0.895-0.972)<0.00126.550.7900.950
VFA0.943(0.910-0.976)<0.00187.250.8150.968
RMR0.782(0.696-0.867)<0.0011579.500.6020.900
女性BFR0.893(0.824-0.963)<0.00133.850.8760.812
VFA0.907(0.850-0.965)<0.001117.050.7710.937
RMR0.751(0.644-0.859)0.0011277.500.3990.970
表4 BFR、VFA和RMR预测MAFLD患病风险的Logistic回归分析
未调整
模型Ⅰ
模型Ⅱ
OR(95%CI)POR(95%CI)POR(95%CI)P
合计BFR1.203(1.133-1.277)<0.0011.378(1.261-1.505)<0.0011.357(1.214-1.517)<0.001
VFA1.063(1.043-1.082)<0.0011.077(1.054-1.101)<0.0011.079(1.049-1.111)<0.001
RMR1.004(1.002-1.005)<0.0011.008(1.004-1.011)<0.0011.009(1.005-1.014)<0.001
男性BFR1.453(1.279-1.651)<0.0011.458(1.282-1.658)<0.0011.427(1.209-1.685)<0.001
VFA1.095(1.058-1.132)<0.0011.100(1.062-1.140)<0.0011.120(1.059-1.185)<0.001
RMR1.006(1.003-1.010)<0.0011.007(1.003-1.010)<0.0011.010(1.004-1.015)<0.001
女性BFR1.281(1.143-1.435)<0.0011.292(1.148-1.455)<0.0011.292(1.106-1.510)<0.001
VFA1.058(1.032-1.086)<0.0011.058(1.032-1.086)<0.0011.054(1.020-1.088)<0.001
RMR1.010(1.004-1.017)<0.0011.011(1.004-1.018)<0.0011.010(1.001-1.020)<0.001

引文著录: 贺登花, 张勇湛, 徐亮, 裴佳佳, 张颖, 闫忠芳. 生物电阻抗法测定体脂率、内脏脂肪面积及静息代谢率与代谢相关脂肪性肝病的关系. 世界华人消化杂志 2023; 31(2): 56-65